2297 Stock Overview
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rainmed Medical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.22 |
| 52 Week High | HK$1.09 |
| 52 Week Low | HK$0.14 |
| Beta | 0 |
| 1 Month Change | 1.41% |
| 3 Month Change | -13.25% |
| 1 Year Change | -80.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2297 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 38.5% | 0.1% | 2.5% |
| 1Y | -80.2% | -43.0% | -5.2% |
Return vs Industry: 2297 underperformed the Hong Kong Medical Equipment industry which returned -43% over the past year.
Return vs Market: 2297 underperformed the Hong Kong Market which returned -5.2% over the past year.
Price Volatility
| 2297 volatility | |
|---|---|
| 2297 Average Weekly Movement | 12.4% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.1% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2297's share price has been volatile over the past 3 months.
Volatility Over Time: 2297's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 406 | Yunfei Huo | rainmed.com |
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions.
Rainmed Medical Limited Fundamentals Summary
| 2297 fundamental statistics | |
|---|---|
| Market cap | HK$185.68m |
| Earnings (TTM) | -HK$125.27m |
| Revenue (TTM) | HK$79.18m |
3.2x
P/S Ratio-2.0x
P/E RatioIs 2297 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2297 income statement (TTM) | |
|---|---|
| Revenue | CN¥73.22m |
| Cost of Revenue | CN¥24.67m |
| Gross Profit | CN¥48.55m |
| Other Expenses | CN¥164.38m |
| Earnings | -CN¥115.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.099 |
| Gross Margin | 66.31% |
| Net Profit Margin | -158.20% |
| Debt/Equity Ratio | 3.0% |
How did 2297 perform over the long term?
See historical performance and comparison